35 results
Thumbnail

D3.01 - Association between allergen-related antibodies and clinical phenotypes of IgG4-related disease (IgG4-RD)

Thumbnail

D3.02 - A Well-Established Drug and A Rare Reaction: Successful Desensitization to Adalimumab

Thumbnail

D3.04 - Sensitization Pattern and Characteristics of IgE Repertoire in Allergic Children with Excessively High Serum IgE Levels

Thumbnail

D3.13 - Molecular characterization of food allergens in a case of suspected honey and mustard allergy

Thumbnail

D3.14 - IgE sensitisation to parvalbumin, Ani s 1, tropomyosin and arginine kinase delineates distinct molecular endotypes of seafood allergy

Thumbnail

D3.03 - Titanium allergy – from anamnesis to diagnosis

Thumbnail

D3.06 - Comparative Evaluation of Raw, Blanched, Individual and Composite Allergen Preparation for Basophil Activation Testing

Thumbnail

D3.07 - Low inter-lot variability and high long-term stability of ready-to-use and room temperature-stable dry reagents for Basophil Activation Testing against peanut extracts

Thumbnail

D3.08 - Biomarker Profiles and Autoimmune Features in Patients with Chronic Urticaria: A Clinical–Laboratory Analysis

Thumbnail

D3.09 - Cyto-LTT as a Diagnostic Tool in Acute Drug-Induced Interstitial Nephritis: A Case Report and Laboratory Case Series

Thumbnail

D3.10 - An exploratory assessment of biological inflammatory markers found in nasal epithelial cells from rhinitic patients as prospective predictors of rhinitis exacerbation status

Thumbnail

D3.11 - Identification of allergens in Chicken and Rabbit meat, a case report

Thumbnail

D3.440 - Long-Term Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Analysis of the OASISplus Study

Thumbnail

D3.441 - Switching to Donidalorsen for Hereditary Angioedema: 1-Year Results From the Phase 3 OASISplus Study

Thumbnail

D3.444 - Efficacy and Safety of Donidalorsen for Patients With Hereditary Angioedema in Europe Who Switched From Prior Long-Term Prophylaxis: Results From the OASISplus Study

Thumbnail

D3.445 - Validation of a Novel Serum-Based Indirect Basophil Activation Test (iBAT) to Evaluate Efficacy of a Pivotal Phase III PQ Grass Immunotherapy Trial

Thumbnail

D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial

Thumbnail

D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial

Thumbnail

D3.439 - Donidalorsen For The Treatment Of Hereditary Angioedema: 1-Year Results From The OASISplus Open-Label Extension Cohort

Thumbnail

D3.442 - Patient-Reported Outcomes With Long-Term Donidalorsen Treatment Among Patients In Europe With Hereditary Angioedema: 1-Year Interim Results From The OASISplus Open-Label Extension Cohort